No sub­sidy for mi­graine drug

Mercury (Hobart) - - NEWS -

MI­GRAINE suf­fer­ers have slammed Aus­tralia’s medicine sub­sidy agency for fail­ing to cover the cost of a rev­o­lu­tion­ary drug they say can give them their life back.

Phar­ma­ceu­ti­cal gi­ant No­var­tis has with­drawn its lat­est bid to gain a sub­sidy for its $800-amonth mi­graine pre­ven­tion drug Ai­movig after its first two ap­pli­ca­tions were re­fused by the Phar­ma­ceu­ti­cal Ben­e­fits Ad­vi­sory Com­mit­tee. It was to be con­sid­ered in Novem­ber.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.